
Veradermics, Incorporated: updates and filings
Price
$125.64
November 17, 2026Market cap $5.3B
What Ploutos Investor adds for Veradermics
Part of Ploutos Investor, €9.99 a month
- The full history: 2 fiscal years, from 2024
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
What comes next, and what happened
Its next results and latest dividend, and the filings that told of something: results, deals, people, debt. In plain words, each linked to the filing.
November 2026
August 2026
May 2026
Its SEC filings
What it has filed lately, newest first, linked to the document itself.
- Nov 13, 2026Over-5% holder statement (active) (amendment)FormSCHEDULE 13D/A
- Nov 10, 2026Quarterly reportfor the period to Sep 30, 2026Form10-Q
- Nov 10, 2026Results of operationsForm8-K
- Nov 9, 2026Regulation FD disclosure, other material eventsForm8-K
- Oct 19, 2026Regulation FD disclosure, other material eventsForm8-K
- Oct 13, 2026Over-5% holder statement (passive)FormSCHEDULE 13G
- Aug 21, 2026Over-5% holder statement (active) (amendment)FormSCHEDULE 13D/A
- Aug 14, 2026FilingFormEFFECT
- Aug 14, 2026Over-5% holder statement (active) (amendment)FormSCHEDULE 13D/A
- Aug 14, 2026Filing (amendment)Form144/A
- Aug 11, 2026Quarterly reportfor the period to Jun 30, 2026Form10-Q
- Aug 11, 2026Results of operationsForm8-K
- Aug 7, 2026FilingFormS-1
- Aug 6, 2026Over-5% holder statement (passive)FormSCHEDULE 13G
- Jul 15, 2026Regulation FD disclosure, other material eventsForm8-K
- May 15, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- May 15, 2026FilingFormD
- May 12, 2026Quarterly reportfor the period to Mar 31, 2026Form10-Q
- May 12, 2026Results of operationsForm8-K
- May 7, 2026Over-5% holder statement (passive)FormSCHEDULE 13G
- May 5, 2026Over-5% holder statement (active) (amendment)FormSCHEDULE 13D/A
- May 5, 2026Over-5% holder statement (active) (amendment)FormSCHEDULE 13D/A
- May 5, 2026Over-5% holder statement (active)FormSCHEDULE 13D
- May 1, 2026Material agreement entered, unregistered sale of sharesForm8-K
- Apr 29, 2026FilingFormEFFECT
| Filed | Form | What it is | Filing |
|---|---|---|---|
| Nov 13, 2026 | SCHEDULE 13D/A | Over-5% holder statement (active) (amendment) | Document |
| Nov 10, 2026 | 10-Q | Quarterly reportfor the period to Sep 30, 2026 | Document |
| Nov 10, 2026 | 8-K | Results of operations | Document |
| Nov 9, 2026 | 8-K | Regulation FD disclosure, other material events | Document |
| Oct 19, 2026 | 8-K | Regulation FD disclosure, other material events | Document |
| Oct 13, 2026 | SCHEDULE 13G | Over-5% holder statement (passive) | Document |
| Aug 21, 2026 | SCHEDULE 13D/A | Over-5% holder statement (active) (amendment) | Document |
| Aug 14, 2026 | EFFECT | Filing | Document |
| Aug 14, 2026 | SCHEDULE 13D/A | Over-5% holder statement (active) (amendment) | Document |
| Aug 14, 2026 | 144/A | Filing (amendment) | Document |
| Aug 11, 2026 | 10-Q | Quarterly reportfor the period to Jun 30, 2026 | Document |
| Aug 11, 2026 | 8-K | Results of operations | Document |
| Aug 7, 2026 | S-1 | Filing | Document |
| Aug 6, 2026 | SCHEDULE 13G | Over-5% holder statement (passive) | Document |
| Jul 15, 2026 | 8-K | Regulation FD disclosure, other material events | Document |
| May 15, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| May 15, 2026 | D | Filing | Document |
| May 12, 2026 | 10-Q | Quarterly reportfor the period to Mar 31, 2026 | Document |
| May 12, 2026 | 8-K | Results of operations | Document |
| May 7, 2026 | SCHEDULE 13G | Over-5% holder statement (passive) | Document |
| May 5, 2026 | SCHEDULE 13D/A | Over-5% holder statement (active) (amendment) | Document |
| May 5, 2026 | SCHEDULE 13D/A | Over-5% holder statement (active) (amendment) | Document |
| May 5, 2026 | SCHEDULE 13D | Over-5% holder statement (active) | Document |
| May 1, 2026 | 8-K | Material agreement entered, unregistered sale of shares | Document |
| Apr 29, 2026 | EFFECT | Filing | Document |
From the company's record at the SEC (EDGAR). The topics of each 8-K are the item codes the company itself filed. Its whole record at the SEC, since Oct 9, 2020.
The full analysis
What do Veradermics's filings show?
The filings are where every one of Veradermics's figures comes from. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.